share_log

Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Raises Price Target to $47

Benzinga ·  Jan 9 08:38

Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and raises the price target from $44 to $47.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment